Aprea Therapeutics, Inc. (APRE)
Financing Cash Flow
$36.89M
TTM · Period ending: · USD
APRE Financing Cash Flow
Latest reported$36.89Mperiod ending
Latest reported$36.89Mperiod ending
APRE Cash from Financing ($23.34M → $36.89M)
Annual financing cash flow
High-resolution chart · PNG
APRE financing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 4,640,238 | |
| 14,821,895 | |
| 5,139,990 | |
| 682,973 | |
| 1,747,012 | |
| 150,949 | |
| 92,575,538 | |
| 56,366,742 | |
| 23,343,863 |